NEXN and cardiomyopathy: To further investigate the role of Nexilin in cardiomyopathy, we established a mouse model carrying the glycine deletion at position 645 (G645del, a mutation corresponding to G650del in patients) of the Nexilin gene by using the CRISPR/Cas9 system [20].